Skip to content
Home » Blog » Intestinal barrier in human health and disease

Intestinal barrier in human health and disease

Intestinal barrier in human health and disease

Major Gheorghe GIURGIU1,Prof dr Manole COJOCARU2,3

1Deniplant-Aide Sante Medical Center, Biomedicine, Bucharest, Romania

deniplant@gmail.com; Telephone: +40 744 827 881

https://orcid.org/0000-0002-5449-2712

2Academy of Romanian Scientists

3Titu Maiorescu University, Faculty of Medicine, Bucharest, Romania

cojocaru.manole@gmail.com; Telephone: +40 723 326 663
https://orcid.org/0000-0002-7192-7490

Background The intestinal mucosa provides a selective permeable barrier for nutrient absorption and protection from external factors. It consists of epithelial cells, immune cells and their secretions. The gut microbiota participates in regulating the integrity and function of the intestinal barrier in a homeostatic balance. Pathogens, xenobiotics and food can disrupt the intestinal barrier, promoting systemic inflammation and tissue damage. 

Objectives Many factors influence microbial dysbiosis such as diet, stress, drugs, diseases, age, and lifestyle. To demonstate the link between Imuniplant, the gut microbiota composition and metabolic activity, and the management of intestinal barrier. 

Materials and methods Understanding how gut microbes can trigger or protect from systemic autoimmune diseases is crucial. Dysbiosis in the gut can also drive systemic autoimmune diseases. 

Results Genetic and immune factors predispose individuals to gut barrier dysfunction, and changes in the composition and function of the gut microbiota are central to this process. The progressive identification of these changes has led to the development of the concept of ‘leaky gut syndrome’ and ‘gut dysbiosis’, which underlie the relationship between intestinal barrier impairment, metabolic diseases and autoimmunity.    

Conclusion  Gut microbes, or their secreted metabolites, directly interact with gut-associated lymphoid tissues. Microbial dysbiosis disturbs the immune function leading to inflammation and sensitization of the immune system and causing autoimmune diseases. Microbial dysbiosis is strongly linked to local inflammation and autoimmune diseases.

Keywords intestinal barrier; microbiome, autoimmune diseases, dysbiosis, Imuniplant

Giurgiu Gheorghe
Author: Giurgiu Gheorghe

2023 Lansare magazin online 2022 Participare conferinte si congrese 2021 deniplant.com 2020 deniplant.eu 2020 Emisiunea Meloterapia si Meloterapia altfel 2020 Imuniplant Cito Remediu natural Anti HPV Oncogen 2019 Infiintarea Centrului de Biomedicina Deniplant- Aide Sante 2018 Grup de sprijin pentru persoanele paralizate. 2018 Neuromodulator al microbiomului. 2018 Artropol pentru afectiunile articulatiilor 2017 Imunomodulator natural al microbiomunui. 2016 Neuropolen - Regenerator natural al celulei nervoase. Remediu natural ce lupta cu paralizia 2015 Infiintarea Centrului de Wellness -Spa Biobreaza 2014 Polenoderm- Pentru o piele curata fara cosuri sau furunculi pe cale naturala . 2014 Sforamin produs nou pentru inlaturarea sforaitului pe cale naturala 2013 Polenoplasmin, pentru tratarea paraliziei la animale. 2012 Antistres Ceai de plante medicinale pentru combaterea efectelor cauzate de stres. 2011 Alergiplant Ceai de plante medicinale pentru alergii. 2010 Stoc caderii parului Plante pentru tinctura. 2010 Imuniplant Ceai de plante medicinale pentru afectiuni autoimune. 2009 Ceai Post operator pentru recuperarea rapida dupa interventii chirurgicale. 2009 Fructimet Ceai dun fructe de padure pentru afectiuni metabolice. 2009 Deniplant a devenit Marca Comunitara Europeana , fiind inregistrata la OHIM detalii.. 2008 Compania Deniplant JA a castigsat cu Deniplant Kids premiul I competitia Company of the Year 2008 organizat de Junior Achievement Romania si...